Back
Neumora Therapeutics, Inc. Stock Price Chart
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
37
NMRA
Neumora Therapeutics, Inc.
Last Price:
$1.96
Seasonality Move:
-24.63%
7 Day Trial
ALL ACCESS PASS
$
7
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NMRA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Neumora Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.16 | Sell |
| 20-day SMA: | 2.3 | Sell |
| 50-day SMA: | 2.3 | Sell |
| 200-day SMA: | 1.49 | Buy |
| 8-day EMA: | 2.15 | Sell |
| 20-day EMA: | 2.26 | Sell |
| 50-day EMA: | 2.23 | Sell |
| 200-day EMA: | 2.74 | Sell |
Neumora Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 40.68 | Sell |
| Chaikin Money Flow: | 371692 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.15 - 2.63) | Sell |
| Bollinger Bands (100): | (1.59 - 2.43) | Buy |
Neumora Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neumora Therapeutics, Inc. Stock
Is Neumora Therapeutics, Inc. Stock a Buy?
-
Neumora Therapeutics, Inc. share price is 2.09 while NMRA 8-day simple moving average is 2.16, which is a Sell signal.
-
The stock price of NMRA is 2.09 while Neumora Therapeutics, Inc. 20-day SMA is 2.30, which makes it a Sell.
-
Neumora Therapeutics, Inc. 50-day simple moving average is 2.30 while NMRA share price is 2.09, making it a Sell technically.
-
NMRA stock price is 2.09 and Neumora Therapeutics, Inc. 200-day simple moving average is 1.49, creating a Buy signal.
NMRA Technical Analysis vs Fundamental Analysis
Sell
37
Neumora Therapeutics, Inc. (NMRA)
is a Sell
Is Neumora Therapeutics, Inc. a Buy or a Sell?
-
Neumora Therapeutics, Inc. stock is rated a SellThe current Neumora Therapeutics, Inc. [NMRA] share price is $2.09. The Score for NMRA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Neumora Therapeutics, Inc. Stock Info
Market Cap:
349.2M
Price in USD:
2.09
Share Volume:
618.4K
Neumora Therapeutics, Inc. 52-Week Range
52-Week High:
11.57
52-Week Low:
0.61
Sell
37
Neumora Therapeutics, Inc. (NMRA)
is a Sell
Neumora Therapeutics, Inc. Share Price Forecast
-
What is the Neumora Therapeutics, Inc. stock price today?The Neumora Therapeutics, Inc. stock price is 2.09 USD today.
-
Will NMRA stock go up or go down?Neumora Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Neumora Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neumora Therapeutics, Inc. is overvalued.
Is Neumora Therapeutics, Inc. Stock a Buy?
-
Neumora Therapeutics, Inc. share price is 2.09 while NMRA 8-day exponential moving average is 2.15, which is a Sell signal.
-
The stock price of NMRA is 2.09 while Neumora Therapeutics, Inc. 20-day EMA is 2.26, which makes it a Sell.
-
Neumora Therapeutics, Inc. 50-day exponential moving average is 2.23 while NMRA share price is 2.09, making it a Sell technically.
-
NMRA stock price is 2.09 and Neumora Therapeutics, Inc. 200-day simple moving average is 2.74, creating a Sell signal.
Fundamental Analysis of Neumora Therapeutics, Inc.
Is Neumora Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.40 per share.
Technical Analysis of Neumora Therapeutics, Inc.
Should I short Neumora Therapeutics, Inc. stock?
-
NMRA Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Neumora Therapeutics, Inc. is a Sell
-
Neumora Therapeutics, Inc. Relative Strength Index (RSI) is 40.68, which suggest Neumora Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Neumora Therapeutics, Inc. is (2.15 - 2.63), which suggest Neumora Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Neumora Therapeutics, Inc. is (1.59 - 2.43), which suggest Neumora Therapeutics, Inc. is a Buy
* Neumora Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.